![Aaron Gray](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 141 064 $ al 31/05/2026
Aaron Gray is currently Chief Executive & Financial Officer at Mayne Pharma Group Ltd., a position held since 2026.
Education includes undergraduate and MBA degrees from the University of Central Florida.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 30/06/2025 | 81.691 ( 0,1 % ) | 141 064 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MAYNE PHARMA GROUP LIMITED | Director Ejecutivo | 20/02/2026 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
University of Central Florida
 University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mayne Pharma Group Ltd.
 Mayne Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company, which develops and manufactures proprietary and generic products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
